SLC12A2 and Down syndrome: For example, a newly discovered small molecule ARN23746, a selective inhibitor of NKCC1, was shown to improve Down syndrome and autism symptoms in murine models of these diseases and restore [Cl−]i in in vitro murine Down syndrome neuronal cultures [94].